Cargando…
Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer
BACKGROUND: Advanced ovarian cancer is the leading non-breast gynaecologic cause of malignant pleural effusion. Aim of this study was to assess the efficacy of mitoxantrone sclerotherapy as a palliative treatment of malignant pleural effusions due to ovarian cancer. METHODS: Sixty women with known o...
Autores principales: | Barbetakis, Nikolaos, Vassiliadis, Michalis, Kaplanis, Konstantinos, Valeri, Rosalia, Tsilikas, Christodoulos |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC520817/ https://www.ncbi.nlm.nih.gov/pubmed/15357871 http://dx.doi.org/10.1186/1472-684X-3-4 |
Ejemplares similares
-
Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer
por: Barbetakis, Nikolaos, et al.
Publicado: (2004) -
Cardiac Tamponade Secondary to Metastasis from Adenocarcinoma of the Parotid Gland
por: Barbetakis, Nikolaos G, et al.
Publicado: (2003) -
Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases
por: Barbetakis, Nikolaos, et al.
Publicado: (2010) -
Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion
por: Ibrahim, Islam M, et al.
Publicado: (2015) -
Efficacy and Safety of Povidone-iodine Pleurodesis in Malignant Pleural Effusions
por: Kahrom, Hadi, et al.
Publicado: (2017)